Geninus Inc
KOSDAQ:389030
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Geninus Inc
Research & Development
Geninus Inc
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
G
|
Geninus Inc
KOSDAQ:389030
|
Research & Development
-₩2.2B
|
CAGR 3-Years
20%
|
CAGR 5-Years
-54%
|
CAGR 10-Years
N/A
|
|
|
Celltrion Inc
KRX:068270
|
Research & Development
-₩208B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-14%
|
|
|
SK Bioscience Co Ltd
KRX:302440
|
Research & Development
-₩69.9B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
N/A
|
|
|
V
|
Voronoi Inc
KOSDAQ:310210
|
Research & Development
-₩17.9B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
|
Alteogen Inc
KOSDAQ:196170
|
Research & Development
-₩28.4B
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-35%
|
CAGR 10-Years
-31%
|
|
|
A
|
ABL Bio Inc
KOSDAQ:298380
|
Research & Development
-₩93B
|
CAGR 3-Years
-24%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
N/A
|
|
Geninus Inc
Glance View
GENINUS, Inc. is engaged in the research and development of NGS (Next Generation Sequencing)-based genome analysis technology, development and manufacturing of genome analysis solutions. The company is headquartered in Seoul, Seoul. The company went IPO on 2021-11-08. The firm is engaged in the provision of single cell analysis services, genetic testing for disease prediction for the public, cancer genome analysis solutions based on tissue biopsy and other services. The company is also engaged personal genetic testing, software development, rental business and others.
See Also
What is Geninus Inc's Research & Development?
Research & Development
-2.2B
KRW
Based on the financial report for Dec 31, 2024, Geninus Inc's Research & Development amounts to -2.2B KRW.
What is Geninus Inc's Research & Development growth rate?
Research & Development CAGR 5Y
-54%
Over the last year, the Research & Development growth was 0%. The average annual Research & Development growth rates for Geninus Inc have been 20% over the past three years , -54% over the past five years .
